Abstract. Aqueous human placenta extract (HPE) has been previously used to treat chronic soft tissue ulcer; however, the optimal dosage of HPE has yet to be elucidated. The present study investigated a novel nanofiber gel composed through layer-by-layer (LbL) self-assembly, in which HPE was encapsulated. IKVAV, RGD, RAD16 and FGL-PA were screened and combined to produce an optimal vehicle nanofiber gel through LbL assembly. Subsequently, the aqueous HPE was encapsulated into this nanofiber at the appropriate concentration, and the morphology, particle size, drug loading efficacy, encapsulation rate, release efficiency and structure validation were detected. The encapsulation efficiency of all three HPE samples was >90%, the nanofiber gel exhibited a slow releasing profile, and the structure of HPE encapsulated in the nanofiber gel was unvaried. In conclusion, this type of novel composite nanocapsules may offer a promising delivery system for HPE.
Abstract:In this work, after investigating three typical magneto-electric (ME) composites, Permendur/Pb(Zr0.52Ti0.48)O3(PZT), Metglas/PZT, and Tefenol-D/PZT, with the same dimensions and different saturation magnetostriction and magnetic permeability, the most excellent ME performance is observed in the Permendur/PZT laminates, which agrees well with the predicted results from the figure of merit. The low-frequency and resonance ME coefficients of Permendur/PZT composite are ~23.1 V/Oe.cm and ~309 V/Oe.cm at the optimal dc bias magnetic field of ~250 Oe, respectively. The strong ME effect of Permendur/PZT composite gives it potential in practical magnetic sensitive device applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.